AGN194310 (VTP-194310) is a potent, high-affinity, and selective pan-antagonist of retinoic acid receptors (RARs), with Kd values of 3 nM, 2 nM, and 5 nM for RARα, RARβ, and RARγ, respectively; it inhibits colony formation in LNCaP, PC-3, and DU-145 prostate cancer cell lines with IC50 values of 16 nM, 18 nM, and 34 nM, respectively; induces apoptosis in LNCaP cells (80% apoptosis at 1 μM after 72 hours); and increases granulocyte numbers and granulocyte-progenitor frequency in hematopoietic compartments in vivo in female C57Bl/6J mice following oral administration (0.5 mg/kg/day for 10 days).